Sildenafil

Effects

Overview

A medication originally developed to lower blood pressure, and now widely used to treat erectile dysfunction in men. Do not mix with anything that lowers blood pressure. Contact EMS if erection lasts longer than 4 hours. TS

Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. It is unclear if it is effective for treating sexual dysfunction in females. It can be taken orally (swallowed by mouth), intravenously (injection into a vein), or through the sublingual route (dissolved under the tongue). Onset when taken orally is typically within twenty minutes and lasts for about two hours.[1–4] WP

Common side effects include headaches, heartburn, and flushed skin. Caution is advised in those with cardiovascular disease. Rare but serious side effects include vision problems, hearing loss, and prolonged erection (priapism) that can lead to damage to the penis. Sildenafil should not be taken by people on nitric oxide donors such as nitroglycerin, as this may result in a serious drop in blood pressure.[2] WP

Sildenafil acts by blocking phosphodiesterase 5 (PDE5), an enzyme that promotes breakdown of cGMP, which regulates blood flow in the penis. It requires sexual arousal to work, and does not by itself cause or increase sexual arousal. It also results in dilation of the blood vessels in the lungs.[2] WP

Pfizer originally discovered the medication in 1989 while looking for a treatment for angina. It was approved for medical use in the United States and in the European Union in 1998. In 2023, it was the 151st most commonly prescribed medication in the United States, with more than 3 million prescriptions. It is available as a generic medication. In the United Kingdom, it is available as a pharmacy medicine.[2][5–12] WP

History

History

Sildenafil (compound UK-92,480) was synthesized in 1989 by a group of pharmaceutical chemists led by Simon Campbell working at Pfizer's Sandwich, Kent, research facility in England. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a symptom of ischaemic heart disease). The first clinical trials were conducted in Morriston Hospital in Swansea. Phase I clinical trials under the direction of Ian Osterloh suggested the drug had little effect on angina, but it could induce marked penile erections. Pfizer therefore decided to market it for erectile dysfunction, rather than for angina; this decision became an often-cited example of drug repositioning. The drug was patented in 1996, approved for use in erectile dysfunction by the FDA on 27 March 1998, becoming the first oral treatment approved to treat erectile dysfunction in the United States, and offered for sale in the United States later that year. It soon became a great success: annual sales of Viagra peaked in 2008 at US$1.934 billion.[13–21] WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.

Legal status

Marketing and sales

In the US, even though sildenafil is available only by prescription from a doctor, it was advertised directly to consumers on TV (famously being endorsed by former United States Senator Bob Dole and football star Pelé). Numerous sites on the Internet offer Viagra for sale after an "online consultation", often a simple web questionnaire.[22][23] WP

Viagra and other products for sexual dysfunction, termed sexuopharmaceuticals, proliferated new types of specialised marketing for such products. Viagra and similar prescription pharmaceuticals were promoted by images in media to the extent of becoming a cultural icon, at the time a relatively new phenomenon known to be permitted only in the United States and New Zealand and which is believed to have significantly contributed to norms regarding male sexuality. One author notes that although the effect of Viagra is only limited to penile blood vessels, advertisements routinely use imagery of couples hugging, smiling and dancing, with the author claiming that pharmaceutical companies were deceptive in the use of such advertisements.[24][25][26] WP

In 2000, Viagra sales accounted for 92% of the global market for prescribed erectile dysfunction pills. By 2007, Viagra's global share had plunged to about 50% due to several factors, including the entry of Cialis and Levitra, along with several counterfeits and clones, and reports of vision loss in people taking PDE5 inhibitors. In 2008, the FDA forced Pfizer to remove Viva Cruiser, an advergame for Viagra, from appearing on Forbes, after the game failed to disclose risk information about the drug.[27–32] WP

In February 2007, it was announced that Boots, the UK pharmacy chain, would try over-the-counter sales of Viagra in stores in Manchester, England. Males between the ages of 30 and 65 would be eligible to buy four tablets after a consultation with a pharmacist. In 2017, the Medicines and Healthcare products Regulatory Agency (MHRA) enacted legislation that expanded this nationwide, allowing a particular branded formulation of Sildenafil, Viagra Connect (50 mg), to be sold over the counter and without a prescription throughout the UK from early 2018. While the sale remains subject to a consultation with a pharmacist, the other restrictions from the trial have been removed, allowing customers over the age of 18 to purchase an unlimited number of pills.[33][34][35] WP

In May 2013, Pfizer, which manufactures Viagra, told the Associated Press they will begin selling the drug directly to people on its website.[36] WP

Pfizer's patents on Viagra expired outside the US in 2012; in the US they were set to expire, but Pfizer settled litigation with each of Mylan and Teva which agreed that both companies could introduce generics in the US in December 2017. In December 2017, Pfizer released its own generic version of Viagra.[37–40] WP

As of 2018, the US Food and Drug Administration has approved fifteen drug manufacturers to market generic sildenafil in the United States. Seven of these companies are based in India.[41][42] WP

The patent for Pfizer's Viagra sildenafil to treat erectile dysfunction expired in April 2020.[43] WP

In 2026 a chocolate syrup called Boner Bears from Lockout Supplements was recalled through the FDA because of it containing Sildenafil as an undisclosed ingredient.[44][45] WP

Counterfeits

Counterfeit Viagra, despite generally being cheaper, can contain harmful substances or substances that affect how Viagra works, such as blue printer ink, amphetamines, metronidazole, boric acid, and rat poison.[46][47] WP

Viagra is one of the world's most counterfeited medicines. According to a 2012 Pfizer study, around 80% of sites claiming to sell Viagra were selling counterfeits.[47][48][49] WP

An October 2023 release stated that erectile dysfunction medicines were the most seized drugs by the Interpol accounting for 22% of seizures. International networks may be active.[50–53] WP

United states

In 1992, Pfizer filed a patent covering the substance sildenafil and its use to treat cardiovascular diseases. This would be marketed as Revatio. The patent was published in 1993 and expired in 2012. The patent on Revatio (indicated for pulmonary arterial hypertension rather than erectile dysfunction) expired in late 2012. Generic versions of this low-dose form of sildenafil have been available in the US from a number of manufacturers, including Greenstone, Mylan, and Watson, since early 2013. Health care providers may prescribe generic sildenafil for erectile dysfunction. For a time, the generic was not available in the same dosages as branded Viagra, so using dosages typically required for treating ED required patients to take multiple pills.[54][55][56] WP

In 1994, Pfizer filed a patent covering the use of sildenafil to treat erectile dysfunction. This would be marketed as Viagra. This patent was published in 2002 and expired in 2019. Teva sued to have the latter patent invalidated, but Pfizer prevailed in an August 2011 federal district court case. An agreement with Pfizer allowed Teva to begin to provide the generic drug in December 2017.[56][57][58] WP

In the United States, Pfizer received two patents for sildenafil: one for its indication to treat cardiovascular disease (marketed as Revatio) and another for its indication to treat erectile dysfunction (marketed as Viagra). The substance is the same under both brand names.[56] WP

Sildenafil is available as a generic drug in the United States, labeled for pulmonary arterial hypertension, and to treat erectile dysfunction, as the patent expired in April 2020.[43][56] WP

In the US, Revatio and Viagra are marketed by Viatris after Upjohn was spun off from Pfizer.[59–62] WP

Brazil

Pfizer's patent on sildenafil citrate expired in Brazil in 2010.[63] WP

Canada

In Canada, Pfizer's patent 2,324,324 for Revatio (sildenafil used to treat pulmonary hypertension) was found invalid by the Federal Court in June 2010, on an application by Ratiopharm Inc.[64][65] WP

On 8 November 2012, the Supreme Court of Canada ruled that Pfizer's patent 2,163,446 on Viagra was invalid from the beginning because the company did not provide full disclosure in its application. The decision, Teva Canada Ltd. v. Pfizer Canada Inc., pointed to section 27(3)(b) of The Patent Act which requires that disclosure must include sufficient information "to enable any person skilled in the art or science to which it pertains" to produce it. It added further: "As a matter of policy and sound statutory interpretation, patentees cannot be allowed to 'game' the system in this way. This, in my view, is the key issue in this appeal." WP

Teva Canada launched Novo-Sildenafil, a generic version of Viagra, on the day the Supreme Court of Canada released its decision. To remain competitive, Pfizer then reduced the price of Viagra in Canada. However, on 9 November 2012, Pfizer filed a motion for a re-hearing of the appeal in the Supreme Court of Canada, on the grounds that the court accidentally exceeded its jurisdiction by voiding the patent. Finally, on 22 April 2013, the Supreme Court of Canada invalidated Pfizer's patent altogether.[66–72] WP

China

Manufacture and sale of sildenafil citrate drugs is common in China, where Pfizer's patent claim is not widely enforced. WP

Egypt

Egypt approved Viagra for sale in 2002, but soon afterwards allowed local companies to produce generic versions of the drug, citing the interests of poor people who would not be able to afford Pfizer's price.[73] WP

European union

In June 2013 Pfizer's patent on sildenafil citrate expired in some member countries of the European Union, including Austria, Denmark, France, Germany, Ireland, Italy, The Netherlands, Spain, Sweden, the United Kingdom, and Switzerland. A UK patent held by Pfizer on the use of PDE5 inhibitors (see below) as treatment of impotence was invalidated in 2000 because of obviousness; this decision was upheld on appeal in 2002.[74–78] WP

India

Manufacture and sale of sildenafil citrate drugs known as "generic Viagra" is common in India, where Pfizer's patent claim does not apply. Brand names include Kamagra (Ajanta Pharma), Silagra (Cipla), Edegra (Sun Pharmaceutical), Penegra (Zydus Cadila), Manly (Cooper Pharma) and Zenegra (Alkem Laboratories). WP

New zealand

Sildenafil was reclassified in New Zealand in 2014 so it could be bought over the counter from a pharmacist. It is thought that this reduced sales over the Internet and was safer as males could be referred for medical advice if appropriate.[79] WP

South korea

In 1999 South Korea granted two patents to Pfizer related to sildenafil. The first document guaranteed sole production and sale of the substance until 2012, while the second gave Pfizer the exclusive use to treating erectile dysfunction with sildenafil until 2014. In 2011 Hanmi Pharmaceutical and CJ CheilJedang launched a suit against the exclusive use patent. The Korean Court system made a ruling against Pfizer in June 2012, allowing for the unhindered domestic production of generic prescription sildenafil.[80][81] WP

In 2012, Viagra lost its position as the top selling erectile dysfunction treatment in South Korea. This development was credited largely "due to the introduction of generic products." Generic sildenafil became publicly available in May. Sales of PalPal by Hanmi Pharmaceuticals totalled ₩22 billion or about 86% the market share of Viagra that year. By 2017, there were over 50 generic sildenafil pills available. During that year Viagra sales slumped to 38% that of Palpal.[82][83] WP

United kingdom

There were 2,958,199 prescriptions for Sildenafil in 2016 in England, compared with 1,042,431 in 2006.[84] WP

In 2018, Viagra Connect, a particular formulation of Sildenafil marketed by Pfizer, became available for sale without a prescription in the UK.[35][85][86][87] WP

Pharmacology

Detection in biological fluids

Sildenafil and/or N-desmethylsildenafil, its major active metabolite, may be quantified in plasma, serum, or whole blood to assess pharmacokinetic status in those receiving the drug therapeutically, to confirm the diagnosis in potential poisoning victims, or to assist in the forensic investigation in a case of fatal overdose.[88] WP

Mechanism of action

Sildenafil protects cyclic guanosine monophosphate (cGMP) from degradation by cGMP-specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum. Nitric oxide (NO) in the corpus cavernosum of the penis binds to guanylate cyclase receptors, which results in increased levels of cGMP, leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries. This smooth muscle relaxation leads to vasodilation and increased inflow of blood into the spongy tissue of the penis, causing an erection. Robert F. Furchgott, Ferid Murad, and Louis Ignarro won the Nobel Prize in Physiology or Medicine in 1998 for their independent study of the metabolic pathway of nitric oxide in smooth muscle vasodilation.[89] WP

The molecular mechanism of smooth muscle relaxation involves the enzyme CGMP-dependent protein kinase, also known as PKG. This kinase is activated by cGMP and it phosphorylates multiple targets in the smooth muscle cells, namely myosin light chain phosphatase, RhoA, IP3 receptor, phospholipase C, and others. Overall, this results in a decrease in intracellular calcium and desensitizing proteins to the effects of calcium, engendering smooth muscle relaxation.[90] WP

Sildenafil is a potent and selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5), which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and increased penile response to sexual stimulation. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra).[89][91] WP

Sildenafil is broken down in the liver by hepatic metabolism using cytochrome p450 enzymes, mainly CYP450 3A4 (major route), but also by CYP2C9 (minor route) hepatic isoenzymes. The major product of metabolisation by these enzymes is N-desmethylated sildenafil, which is metabolised further. This metabolite also has an affinity for the PDE receptors, about 40% of that of sildenafil. Thus, the metabolite is responsible for about 20% of sildenafil's action. Sildenafil is excreted as metabolites predominantly in the feces (about 80% of administered oral dose) and to a lesser extent in the urine (around 13% of the administered oral dose). If taken with a high-fat meal, absorption is reduced; the time taken to reach the maximum plasma concentration increases by around one hour, and the maximum concentration itself is decreased by nearly one-third.[92] WP

Chemistry

Formula

C22H30N6O4S PC

CAS number

139755-83-2 PC

Molar mass (g/mol)

474.6 PC

IUPAC name (computed by PubChem)

5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one PC

SMILES

CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C PC

InChIKey

BNRNXUUZRGQAQC-UHFFFAOYSA-N PC

PubChem CID

135398744

Pop culture

No references added yet.

References

1. Journal / agency Viagra- sildenafil citrate tablet, film coated
2. Other Sildenafil Citrate
3. Journal / agency Roustit M, Blaise S, Allanore Y, Carpentier PH, Caglayan E, Cracowski JL. Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Annals of the Rheumatic Diseases. October 2013. doi:10.1136/annrheumdis-2012-202836 · PMID 23426043
4. Journal / agency Deveci S, Peşkircioğlu L, Aygün C, Tekin MI, Dirim A, Ozkardeş H. Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose. International Journal of Urology. November 2004. doi:10.1111/j.1442-2042.2004.00933.x · PMID 15509203
5. Journal / agency Goldstein I, Burnett AL, Rosen RC, Park PW, Stecher VJ. The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction. Sexual Medicine Reviews. January 2019. doi:10.1016/j.sxmr.2018.06.005 · PMID 30301707
6. Journal / agency Viagra EPAR. 17 September 2018
7. Journal / agency Drug Approval Package: Viagra (sildenafil citrate) NDA #020895. 27 March 1998
8. Other Top 300 of 2023
9. Other Sildenafil Drug Usage Statistics, United States, 2014 - 2023
10. Other Gordon S. Generic Viagra: Two versions of sildenafil hit the market today. 11 December 2017
11. Journal / agency Competitive Generic Therapy Approvals. 3 March 2023
12. Other LaMattina J. With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?
13. Journal / agency Scientist who developed Viagra receives knighthood in New Year's Honours. The Pharmaceutical Journal. 2014. doi:10.1211/pj.2014.20067494
14. Journal / agency Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. August 2006. doi:10.1038/nrd2030 · PMID 16883306 · PMC7097805
15. Other Research. 4 July 2008
16. Journal / agency Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. International Journal of Impotence Research. June 1996. PMID 8858389
17. Journal / agency Terrett NK, Bell AS, Brown D, Elllis P. Sildenafil (Viagra), a potent and selective inhibitor of Type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Lett. 1996. doi:10.1016/0960-894X(96)00323-X
18. Journal / agency Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery. August 2004. doi:10.1038/nrd1468 · PMID 15286734
19. Other Institute of Medicine. Drug Repurposing and Repositioning: Workshop Summary. 2014
20. Journal / agency Kling J. From hypertension to angina to Viagra. Mod. Drug Discov. 1998
21. Other Portions of the 2010 Financial Report
22. Journal / agency Ciment J. Health situation in former communist bloc is dire, says Unicef. BMJ. November 1999. doi:10.1136/bmj.319.7221.1324g · PMID 10567131 · PMC1174637
23. Other Devine A. Chemists plan to sell Viagra on the internet. 29 September 2008
24. Journal / agency Gurevich M, Cormier N, Leedham U, Brown-Bowers A. Sexual dysfunction or sexual discipline? Sexuopharmaceutical use by men as prevention and proficiency. Feminism & Psychology. August 2018. doi:10.1177/0959353517750682
25. Journal / agency Vares T, Braun V. Spreading the Word, but What Word is That? Viagra and Male Sexuality in Popular Culture. Sexualities. July 2006. doi:10.1177/1363460706065055
26. Journal / agency Tiefer L. A new view of women's sexual problems: Why new? Why now?. The Journal of Sex Research. 1 May 2001. doi:10.1080/00224490109552075
27. Journal / agency Keith A. The economics of Viagra. Health Affairs. 2000. doi:10.1377/hlthaff.19.2.147 · PMID 10718028
28. Other McGuire S. Cialis gaining market share worldwide. 1 January 2007
29. Journal / agency Mullin R. Viagra. Chemical & Engineering News. 20 June 2005
30. Other Berenson A. Sales of Impotence Drugs Fall, Defying Expectations. 4 December 2005
31. Other Pfizer Courting More Controversy with Viagra 'Advergaming'. 3 September 2008
32. Other FDA gave Pfizer hard time over Viagra game. 24 November 2008
33. Other Over-the-counter Viagra piloted. 11 February 2007
34. Other Viagra can be sold over the counter. 28 November 2017
35. Other Viagra now available over the counter without prescription in the UK. 27 March 2018
36. Other Pfizer to sell Viagra online, in first for Big Pharma: AP
37. Other Helfand C. The coming generics threat to Pfizer's Viagra brand just got scarier. 14 April 2015
38. Other Viagra to go generic in 2017 according to Pfizer agreement. 17 December 2013
39. Other Nocera J. Sex, Drugs and That Little Blue Pill. 6 December 2017
40. Other Mukherjee S. Why Pfizer Is About to Slash Viagra's Price in Half. 6 December 2017
41. Other Chandna H. Pfizer to lose patent of drug Viagra, Indian companies gear up with copycat versions: Pfizer's patent for the formulation of Viagra, used to treat impotence in men, ends in the US in 2020. 7 August 2018
42. Other Set to conquer US, Indian 'Viagras' may give Pfizer a hard Time. 3 August 2018
43. Other Pfizer Settles Viagra® Patent Litigation With Teva
44. Other Chocolate syrup recalled over hidden Viagra. 2026-02-26
45. Journal / agency Investigations, Office of Inspections and. Lockout Supplements Issues Voluntary Nationwide Recall of Boner Bears Chocolate Syrup Due to Undeclared Sildenafil. 2026-02-25
46. Other Record amount of counterfeit Viagra seized. 12 May 2016
47. Other Amerman D. Counterfeit Viagra, Cialis, Levitra: The Ultimate Guide. 22 May 2012
48. Other Moran B. Cracking Down on Counterfeit Drugs. 20 August 2013
49. Other Somra G. Online pharmacies suspected of counterfeit drug sales. 31 August 2015
50. Other Erectile Dysfunction Medication the Most Seized Drug During Global Crackdown, Interpol Says
51. Other Global illicit medicines targeted by INTERPOL operation
52. Other Israeli-made AI exposes international fake Viagra network. 19 April 2023
53. Other Counterfeit Viagra Pills, Footwear, Belts, Car Emblems and Headphones Worth over $32 Million Seized at the LA/Long Beach Seaport | U.S. Customs and Border Protection
54. Other U.S. patent 5250534
55. Other Pfizer's Revatio Goes Generic. 15 November 2012
56. Other Skinner G. Yes, There Is a Way to Get Generic Viagra. 4 March 2016
57. Other U.S. patent 6469012
58. Other Milford P. Pfizer Wins Viagra Patent Infringement Case Against Teva Pharmaceuticals. 15 August 2011
59. Other Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan. 16 November 2020
60. Other Revatio
61. Other Viagra
62. Other Brands. 16 November 2020
63. Other in-PharmaTechnologist.com. Viagra patent expires in June, says Brazilian court. 28 April 2010
64. Other Revatio patent ruled invalid for lack of sound prediction and obviousness. 18 June 2010
65. Other Pfizer Canada Inc. v. Ratiopharm Inc., 2010 FC 612
66. Other Spears J. Supreme Court ruling could lead to cheaper versions of Viagra. 8 November 2012
67. Other Hanly K. Canadian Supreme court rules Viagra patent invalid. 8 November 2012
68. Other Viagra patent tossed out by Supreme Court: Decision allows generic versions of drug to be produced. 8 November 2012
69. Other Pfizer Canada drops Viagra price after generic versions get Supreme Court green light. 22 November 2012
70. Other SCC Case Information, Docket No. 33951. January 2001
71. Other Makin K. In rare move, Pfizer asks Supreme Court to reconsider ruling that killed Viagra patent. 15 November 2012
72. Other Henderson GL, D'Iorio H. The Supreme Court of Canada holds Pfizer's Viagra patent invalid. 22 April 2013
73. Other Allam A. Seeking Investment, Egypt Tries Patent Laws. 4 October 2002
74. Other Actavis Launches Generic Viagra in Europe as Patents Expire. 24 June 2013
75. Other Edwards J. What Will Happen When Viagra Goes Generic?. 21 October 2009
76. Other Is Viagra about to lose its pulling power in the UK?. 3 June 2013
77. Other Murray R. Viagra ruling upsets Pfizer. 23 January 2002
78. Other Pfizer Loses UK Battle on Viagra Patent. 17 June 2002
79. Other Gauld N. Viagra from the pharmacist: insight from reclassification in New Zealand. 31 January 2018
80. Other Generic Viagra developers queue up, but may have to wait. 14 March 2012
81. Other Approved Viagra copies flood drugstores in Korea. 1 June 2012
82. Other Viagra loses top spot in Korean market. 10 April 2013
83. Other Hanmi leads erectile dysfunction drug sales. 12 December 2017
84. Other Viagra prescriptions almost triple in a decade. 12 February 2021
85. Other MHRA reclassifies Viagra Connect tablets to a Pharmacy medicine
86. Other Viagra can be sold over the counter. 28 November 2017
87. Other Viagra to be available without prescription in UK. 28 November 2017
88. Other Sildenafil
89. Journal / agency Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. The American Journal of Cardiology. March 1999. doi:10.1016/S0002-9149(99)00044-2 · PMID 10078539
90. Journal / agency Francis SH, Busch JL, Corbin JD, Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacological Reviews. September 2010. doi:10.1124/pr.110.002907 · PMID 20716671 · PMC2964902
91. Journal / agency Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. The New England Journal of Medicine. May 1998. doi:10.1056/NEJM199805143382001 · PMID 9580646
92. Other Viagra Clinical Pharmacology. 2008

Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), TripSit factsheets, PubChem (public domain). Each value links to the exact revision it came from.